Ibrutinib has some activity in Richter's syndrome

Item

http://www.wikidata.org/entity/Q42358968

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ibrutinib has some activity in Richter's syndrome

@en

Ibrutinib has some activity in Richter's syndrome

@nl

type

Item

label

Ibrutinib has some activity in Richter's syndrome

@en

Ibrutinib has some activity in Richter's syndrome

@nl

prefLabel

Ibrutinib has some activity in Richter's syndrome

@en

Ibrutinib has some activity in Richter's syndrome

@nl

P1476

Ibrutinib has some activity in Richter's syndrome

@en

P2093

A Hahn

http://www.w3.org/2001/XMLSchema#string

G Yaghmour

http://www.w3.org/2001/XMLSchema#string

M G Martin

http://www.w3.org/2001/XMLSchema#string

S Giri

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.

How we treat Richter syndrome.

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

P2888

bcj.2014.98

P304

e277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2014.98

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273954467

http://www.w3.org/2001/XMLSchema#string

P6179

1017604902

http://www.w3.org/2001/XMLSchema#string

P698

25635530

http://www.w3.org/2001/XMLSchema#string

P932

5404220

http://www.w3.org/2001/XMLSchema#string